Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedJul 1, 2020R.E.C.KPresence of Particulate Matter: Fresenius Kabi recalling vials of KetorolacQuVa Pharma, Inc. · D-1335-2020Class IITerminatedJul 1, 2020Metformin Hydrochloride Extended-release Tablets USPCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelLupin Pharmaceuticals Inc. · D-1334-2020Class IITerminatedJul 1, 2020metFORMIN HCL ER 500 mgCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelPD-Rx Pharmaceuticals, Inc. · D-1333-2020Class IITerminatedJul 1, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelTeva Pharmaceuticals USA · D-1332-2020Class IITerminatedJul 1, 2020Metformin Hydrochloride Extended - Release TabletsCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelTeva Pharmaceuticals USA · D-1331-2020Class IITerminatedJul 1, 2020Sterile Curcumin 50mg/mLLack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and CurcuminBIOTA Biosciences LLC · D-1330-2020Class IITerminatedJul 1, 2020Sterile CannabidiolLack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and CurcuminBIOTA Biosciences LLC · D-1329-2020Class IITerminatedJul 1, 2020Sterile CannabidiolLack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and CurcuminBIOTA Biosciences LLC · D-1328-2020Class IITerminatedJul 1, 2020Sterile CurcuminLack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and CurcuminBIOTA Biosciences LLC · D-1327-2020Class IITerminatedJul 1, 2020Sterile CannabidiolLack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and CurcuminBIOTA Biosciences LLC · D-1326-2020Class IITerminatedJun 24, 2020Gaviscon Liquid Antacid Extra StrengthLabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings · D-1325-2020Class IITerminatedJun 24, 2020Gaviscon Extra Strength Liquid Antacid Extra Strength CherryLabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings · D-1324-2020Class IITerminatedJun 24, 2020Gaviscon Regular Strength Liquid Antacid Cool MintLabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings · D-1323-2020Class IITerminatedJun 24, 2020Gaviscon Regular Strength Liquid Antacid Cool MintLabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings · D-1322-2020Class IIITerminatedJun 24, 2020Olanzapine TabletsFailed Impurities/ Degradation SpecificationsAurobindo Pharma USA Inc. · D-1315-2020Class IIITerminatedJun 24, 2020Olanzapine TabletsFailed Impurities/ Degradation SpecificationsAurobindo Pharma USA Inc. · D-1314-2020Class IITerminatedJun 24, 2020Heparin Sodium 5Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.SCA Pharmaceuticals · D-1311-2020Class IITerminatedJun 24, 2020EcoLips Sport Lip BalmSuperpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.Eco Lips Inc · D-1310-2020Class IITerminatedJun 24, 2020Irinotecan HCL InjectionDefective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.Hikma Pharmaceuticals USA Inc. · D-1309-2020Class IITerminatedJun 24, 2020Irinotecan HCL InjectionDefective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.Hikma Pharmaceuticals USA Inc. · D-1308-2020Class IITerminatedJun 24, 2020metFORMIN HCL ER USP 500 mgCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelPD-Rx Pharmaceuticals, Inc. · D-1307-2020Class IITerminatedJun 24, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelAVKARE Inc. · D-1305-2020Class IITerminatedJun 24, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelAVKARE Inc. · D-1304-2020Class IICompletedJun 24, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levelsApotex Inc. · D-1303-2020Class IIITerminatedJun 17, 2020Prednisolone Sodium Phosphate Oral SolutionDiscoloration: Out of Specification (OOS) result for APHA Color Test.Akorn, Inc. · D-1340-2020Class IITerminatedJun 17, 2020Unasyn (ampicillin sodium/sulbacatam) for injectionPresence of Particulate Matter: particulate matter identified after reconstitution.Pfizer Inc. · D-1306-2020Class IITerminatedJun 17, 2020oxyTOCIN 30 Units/500 mLSubpotent drug - Product did not contain drug.QuVa Pharma, Inc. · D-1302-2020Class IITerminatedJun 17, 2020Ketorolac Tromethamine InjectionPresence of Particulate Matter - found in reserve sample vials at the firm.Fresenius Kabi USA, LLC · D-1297-2020Class ITerminatedJun 17, 2020Ketorolac Tromethamine InjectionPresence of Particulate Matter - found in reserve sample vials at the firm.Fresenius Kabi USA, LLC · D-1296-2020Class IITerminatedJun 17, 2020Doxycycline Hyclate TabletsFailed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).American Health Packaging · D-1293-2020Class IIITerminatedJun 17, 2020Clonidine Hydrochloride TabletsFailed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.Unichem Pharmaceuticals USA Inc · D-1291-2020Class IITerminatedJun 17, 2020Lisinopril TabletsProduct Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.Lupin Pharmaceuticals Inc. · D-1290-2020Class IITerminatedJun 10, 2020Carbamazepine TabletsFailed Dissolution SpecificationsTorrent Pharma Inc. · D-1317-2020Class ITerminatedJun 10, 2020NP Thyroid 90Superpotent Drug.Acella Pharmaceuticals, LLC · D-1300-2020Class ITerminatedJun 10, 2020NP Thyroid 60Superpotent Drug.Acella Pharmaceuticals, LLC · D-1299-2020Class ITerminatedJun 10, 2020NP Thyroid 30Superpotent Drug.Acella Pharmaceuticals, LLC · D-1298-2020Class IIITerminatedJun 10, 2020Lamotrigine TabletsPresence of Foreign Substance consistent with granules from desiccant packs used during storageAVKARE Inc. · D-1289-2020Class IITerminatedJun 10, 2020Doxycycline Hyclate TabletsFailed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.The Harvard Drug Group · D-1288-2020Class IITerminatedJun 10, 2020Dextroamphetamine SaccharateSome bottles may contain mixed strengths of the product.Teva Pharmaceuticals USA · D-1287-2020Class IITerminatedJun 10, 2020Dextroamphetamine SaccharateSome bottles may contain mixed strengths of the product.Teva Pharmaceuticals USA · D-1286-2020

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.